Page last updated: 2024-10-27

flurbiprofen and Cancer of Esophagus

flurbiprofen has been researched along with Cancer of Esophagus in 7 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research Excerpts

ExcerptRelevanceReference
"The present study evaluated whether flurbiprofen increased the naturally circulating dendritic cells (DCs) subsets in patients with esophageal squamous cell carcinoma (ESCC) undergoing esophageal resection."5.22A short-term increase of the postoperative naturally circulating dendritic cells subsets in flurbiprofen-treated patients with esophageal carcinoma undergoing thoracic surgery. ( Chai, XQ; Shu, SH; Wang, D; Wei, W; Wei, X; Wu, YJ; Xie, YH; Yang, XL; Zhang, XL, 2016)
"Adenocarcinoma in Barrett's esophagus has been increasing in incidence at a rapid rate for more than two decades."1.31Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. ( Beer, DG; Cryer, B; Shewmake, K; Souza, RF; Spechler, SJ, 2000)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Xie, Y1
Wang, D2
Gao, C1
Hu, J1
Zhang, M1
Gao, W1
Shu, S1
Chai, X1
Sun, J1
Hu, Q1
Zhou, Y1
Huang, J1
Bai, Y1
Li, C1
Lu, X1
Yang, XL1
Chai, XQ2
Shu, SH1
Zhang, XL1
Xie, YH1
Wei, X1
Wu, YJ1
Wei, W1
Liu, ZF1
Chen, KZ1
Wang, Y1
Zhang, HB1
Xia, B1
Wang, GM1
Zhang, MY1
Souza, RF1
Shewmake, K1
Beer, DG1
Cryer, B1
Spechler, SJ1

Trials

4 trials available for flurbiprofen and Cancer of Esophagus

ArticleYear
Effects of preemptive analgesia with flurbiprofen ester on lymphocytes and natural killer cells in patients undergoing esophagectomy: A randomized controlled pilot study.
    Thoracic cancer, 2017, Volume: 8, Issue:6

    Topics: Aged; Analgesics; Antigens, CD19; CD3 Complex; CD4 Antigens; CD8 Antigens; Esophageal Neoplasms; Eso

2017
A short-term increase of the postoperative naturally circulating dendritic cells subsets in flurbiprofen-treated patients with esophageal carcinoma undergoing thoracic surgery.
    Oncotarget, 2016, Apr-05, Volume: 7, Issue:14

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Case-Control Studies; Cytok

2016
Flurbiprofen axetil enhances analgesic effect of fentanyl associated with increase in β-endorphin levels.
    Journal of anesthesia, 2011, Volume: 25, Issue:5

    Topics: Analgesia; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; beta-Endorphin; Drug Synergi

2011
Preemptive analgesic effects of flurbiprofen axetil in patients undergoing radical resection of esophageal carcinoma via the left thoracic approach.
    Chinese medical journal, 2012, Volume: 125, Issue:4

    Topics: Analgesia, Patient-Controlled; Double-Blind Method; Esophageal Neoplasms; Flurbiprofen; Humans

2012

Other Studies

3 other studies available for flurbiprofen and Cancer of Esophagus

ArticleYear
Effect of perioperative flurbiprofen axetil on long-term survival of patients with esophageal carcinoma who underwent thoracoscopic esophagectomy: A retrospective study.
    Journal of surgical oncology, 2021, Volume: 124, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Esophageal Neoplasms; Esophagectomy; Female; Flurbiprofen;

2021
Effect of perioperative flurbiprofen axetil on long-term survival of patients with esophageal carcinoma who underwent thoracoscopic esophagectomy.
    Journal of surgical oncology, 2021, Volume: 124, Issue:8

    Topics: Carcinoma; Esophageal Neoplasms; Esophagectomy; Flurbiprofen; Humans

2021
Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Cancer research, 2000, Oct-15, Volume: 60, Issue:20

    Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Barrett Esophagus; Cell Division

2000